Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why the Street Should Love GlaxoSmithKline's Earnings
Why the Street Should Love GlaxoSmithKline's Earnings
Why the Street Should Love GlaxoSmithKline's Earnings
Submitted by
admin
on August 31, 2011 - 2:19pm
Source:
Motley Fool
News Tags:
GSK
earnings
Headline:
Why the Street Should Love GlaxoSmithKline's Earnings
Do Not Allow Advertisers to Use My Personal information
